Subscribe
Strategy
4 min read

A Shark Tank Water-Bottle Brand Crosses Into Mass Retail, Trading DTC Margins for Target's Shelf

A roughly $2M Shark Tank DTC brand enters Target nationwide with an entry-priced lineup, a live case study in whether a hydration-accessory brand can hold margin and brand control while making the mass-retail jump.

Written by
The Underbite
Published on
July 5, 2026
A Shark Tank Water-Bottle Brand Crosses Into Mass Retail, Trading DTC Margins for Target's Shelf

Here's the current Springland write-up in full.

A Shark Tank Water-Bottle Brand Crosses Into Mass Retail, Trading DTC Margins for Target's Shelf

The hard test for a direct-to-consumer pet brand is not the viral launch, it is the move to mass retail. Springland, the dog-essentials brand formerly known as Springer Pets, put three products in Target stores and on Target.com on July 5, its first major national retail partnership. For a brand built almost entirely on word of mouth and its own website, a big-box slot is less a milestone than a decision about what kind of company it wants to be.

Springland puts three SKUs on Target's national floor

Springland launched a three-SKU assortment at Target nationwide on July 5: a 15-ounce mini travel water bottle at $14.99, a 20-ounce flip travel water bottle with a collapsible silicone flip-top bowl at $24.99, and a new freeze-your-own treat bowl at $14.99 that owners fill with water, broth, or fruit and freeze at home. The lineup leads with accessible price points built for impulse and gift shelves rather than the higher-priced DTC catalog, and ships in color-blocked combinations pitched at the same design-conscious buyer.

The brand's foundation is the patented squeeze-to-drink bottle that made it recognizable. Squeeze the bottle and water fills an attached bowl; release, and the unused water drains back in, leak-tight, BPA-free, dishwasher safe, and clipped to a bag by a carabiner. Founder Shannon Ross took the patented bottle onto Shark Tank in Season 13, where it drew an on-air offer from Lori Greiner. That deal ultimately did not close, and the company grew anyway, riding customer word of mouth, an Amazon storefront, and hundreds of independent pet boutiques. A 2023 nod as one of Oprah's Favorite Things added a second wave of national exposure.

The scale numbers frame the stakes. Springland says its hydration design is now trusted by more than a million dog owners, and outside coverage pegs the Austin-based, women- and family-owned business at roughly two million dollars in annual revenue. Target is the first time that catalog meets a national mass-retail floor.

Why the channel math matters more than the bottles

The Target entry is a channel-strategy inflection, not a product story, and that is exactly why it is worth an operator's attention. Crossing into a big-box retailer means accepting wholesale margins and open shelf competition in exchange for reach a DTC funnel cannot buy at any price. For a brand near two million dollars in revenue, a national slot is simultaneously a growth lever and a commitment that reshapes the P&L: wholesale pricing compresses per-unit margin, retail forecasting dictates inventory and cash, and the customer relationship that DTC brands guard so carefully now runs through a third party.

Plenty of pet accessory brands ride a television moment and a Shopify store to a few million in sales. Far fewer convert that into durable mass-retail distribution without surrendering the margins and direct customer data that made them work in the first place. The entry-tier price ladder is the tell. Leading Target with lower-priced bottles and a freeze-your-own bowl positions the assortment for trial and gifting while, in theory, protecting the premium DTC catalog from direct cannibalization. Whether that separation holds once shoppers can compare the two channels side by side is the open question.

The clearest example of that premium catalog is the brand's personalization line. The Springer-to-Springland rename signals a push beyond the bottle into a broader essentials catalog that now spans personalized collars, leashes, walk bags, and treat dispensers, with customizable silicone name charms and adjustable charm straps that clip onto bottles, collars, and leashes as the personalization hook. Personalization is a quiet lifetime-value engine: low unit cost, high margin, repeat purchase, and emotionally sticky in a way a commodity SKU is not. Those charms are the kind of direct-channel asset a Target slot should funnel customers back toward, not the impulse bottle a shopper grabs off an endcap and forgets.

There is a discipline point worth keeping. Springland's early history includes a widely reported year of roughly 1.7 million dollars in sales that converted to only about 100,000 dollars in profit, a reminder that top-line growth in accessories can mask thin unit economics. Mass retail rewards volume but punishes brands that cannot absorb wholesale margins and chargebacks. The move only pays off if the retail volume more than offsets the compression, and if Springland uses Target as an acquisition funnel back to its higher-margin direct channel rather than a replacement for it.

What the next few quarters will reveal

The signals that matter are all about whether the brand holds its shape inside a big-box environment. Watch the SKU mix and price laddering across channels, whether the Target assortment stays entry-tier while the DTC store keeps the premium and personalized lines, and how aggressively Target merchandises the freeze-your-own bowl as a seasonal impulse item. Channel conflict is the risk to track: if Target pricing undercuts the DTC store, the retail win quietly erodes the margins that funded the brand's independence.

The broader pattern is the one operators should file. A generation of pet brands built on Shark Tank exposure, Amazon, and DTC is now hitting the ceiling of those channels and testing the jump to national retail. Springland is a clean, small-cap case study in that transition, and its next few quarters will show whether a hydration-accessory brand can trade some margin for shelf reach without losing the customer intimacy that got it here. For anyone weighing their own wholesale push, that is the calculation to study.

Source: Submitted directly to The Underbite. Shark Tank deal history, revenue, and product background via Shark Tank Blog.

This news brief is based on a company-submitted announcement. The Underbite verifies claims where possible but cannot independently confirm all details. Revenue and Shark Tank figures reflect third-party reporting.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles